Drug May Delay Need for Prostate Cancer Treatment (01-26-2012)

Among men who choose active surveillance for early-stage prostate cancer, Avodart® (dutasteride) may delay cancer progression and the need for cancer treatment. These results were published in The Lancet. The management of early prostate cancer may involve... Continue Reading

Robotic Surgery May Not Reduce Common Prostatectomy Side Effects (01-11-2012)

Among men who undergo radical prostatectomy for the treatment of early-stage prostate cancer, robotic-assisted laparoscopic surgery may not result in better urinary or sexual function than traditional, open surgery. These results were published in the... Continue Reading

Shorter Course of Radiation Therapy Appears to be Effective for Prostate Cancer (10-11-2011)

Delivering a shorter course of external-beam radiation therapy—with higher doses of radiation given at each visit—appears to be as effective for prostate cancer as the conventional approach to external-beam radiation therapy. These results were presented... Continue Reading

Xgeva Delays Onset of Bone Metastases (09-27-2011)

Among men with prostate cancer that has stopped responding to hormonal therapy, the bone drug Xgeva™ (denosumab) delayed the spread of cancer to the bones. These results were presented at the 2011 European Multidisciplinary Cancer Conference. Androgen... Continue Reading

Predicting Sexual Outcomes After Prostate Cancer Treatment (09-23-2011)

Information about a man’s baseline characteristics and prostate cancer treatment plan can help predict erectile function after treatment. These results were published in the Journal of the American Medical Association. Prostate cancer is the most commonly... Continue Reading

Prolia Approved for Treatment of Bone Loss in Patients with Breast or Prostate Cancer (09-21-2011)

The U.S. Food and Drug Administration (FDA) has expanded the approval of Prolia® (denosumab) to include treatment of bone loss among breast cancer patients treated with aromatase inhibitor therapy and prostate cancer patients treated with androgen deprivation... Continue Reading

Some Prostate Cancer Patients Expect Better Recovery (08-23-2011)

Some men who undergo surgery for prostate cancer expect better recovery of sexual and urinary functions than they actually experience. These findings were recently published in the Journal of Urology. For men who undergo radical prostatectomy (complete... Continue Reading

Hormone Therapy Poses Risks for Prostate Cancer Patients with Heart Problems (08-4-2011)

Among men with early but high-risk prostate cancer treated with radiation therapy, the addition of hormone therapy may worsen outcomes for the subset of men who have a history of congestive heart failure or heart attack. These results were published in... Continue Reading

Addition of Hormonal Therapy to Radiation Therapy Benefits Men with Intermediate-Risk Prostate Cancer (07-18-2011)

For men with localized, intermediate-risk prostate cancer, treatment with a combination of radiation therapy and short-term androgen-deprivation therapy results in better outcomes than treatment with radiation therapy alone. These results were published... Continue Reading

Prostate Cancer Outcomes Worse for Smokers (07-5-2011)

Men who smoke at the time they’re diagnosed with prostate cancer have an increased risk of recurrence and death compared with never smokers. Odds for men who quit smoking at least 10 years previously, on the other hand, are similar to those of never... Continue Reading